✦ LIBER ✦

Phase I study of recombinant leukocyte a interferon (IFN-α2A, roferon-A) with doxorubicin in advanced malignant disease

✍ Scribed by Edward T. Creagan; Stephen Frytak; Harry J. Long; Larry K. Kvols

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 312 KB
Volume: 64
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19890901)64:5<1034::aid-cncr2820640512>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant leukocyte a interferon with

Recombinant leukocyte a interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinoma

✍ E. T. Creagan; H. J. Long; S. Frytak; C. G. Moertel 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB 👁 1 views

A phase I-II trial of the combination of

A phase I-II trial of the combination of recombinant leukocyte a interferon and recombinant human interferon-γ in patients with metastatic malignant melanoma

✍ Edward T. Creagan; Charles L. Loprinzi; David L. Ahmann; Daniel J. Schaid 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

Interferon in combination with vinblasti

Interferon in combination with vinblastine in advanced malignant melanoma. A phase I–II study

✍ Stein Gundersen; A. Flokkmann 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB 👁 2 views

Nineteen patients with advanced malignant melanoma were treated with a combination of recombinant alfa-interferon (a-IFN) and vinblastine (VBL). The a-IFN was administered subcutaneously daily at an initial dose of 3 X lo6 IU escalating to a maximal dose of 9 X lo6 U daily for the first 10 weeks fol

Cisplatin, dacarbazine, and fotemustine

Cisplatin, dacarbazine, and fotemustine plus interferon α in patients with advanced malignant melanoma : A multicenter Phase II study of the Southern Italy Cooperative Oncology Group

✍ Antonio Daponte; Paolo A. Ascierto; Adriano Gravina; Maria Teresa Melucci; Giuse 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

Continuous infusion of high-dose 5-fluor

Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A multicenter phase II study

✍ Cornelis J. A. Punt; Jos Th. M. Burghouts; Jelle J. Croles; Peter A. van Liessum 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

A randomized, controlled phase III study

A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-α maintenance therapy or observation, in small cell lung carcinoma patients with complete responses

✍ Diego Tummarello; Davide Mari; Francesco Graziano; Pierpaolo Isidori; Gianluigi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

BACKGROUND. Studies of chemotherapy for